Trace Medical Buys Majority Stake in CPAP& Respiratory Accessory Maker LiViliti

WHITMORE LAKE, Michigan and SARASOTA, Florida—Respiratory rental company Trace Medical has acquired a majority interest in LiViliti Health Products, Inc., a maker of CPAP and respiratory accessories.

The acquisition follows LiViliti receiving 510(k) clearance from the Food and Drug Administration (FDA) for its Paptizer 360, which is classified as a Class II Respiratory Accessory Microbial Reduction Device for CPAP equipment.

The companies said the majority acquisition builds upon the existing strategic investment between the two organizations, aligning Trace Medical’s expansive nationwide distribution network, biomedical servicing infrastructure and provider reach with LiViliti’s clinical-grade respiratory hygiene technology.

“Partnering with Trace Medical under a majority acquisition provides us with the scale, logistical expertise, and distribution power necessary to make this technology accessible across the continuum of care,” said Brian Sharpe, CEO and founder of LiViliti Health Products.

“LiViliti has demonstrated exceptional innovation in patient safety, equipment hygiene and therapy adherence,” said Greg Apostolou, CEO of Trace Medical. “Together, we are raising the standard of care for CPAP users and healthcare systems nationwide.”